Company Filing History:
1 out of 3 
1 out of 1 
1 out of 4 Years Active: 2017
Title: Waleria Hryniewicz: Innovator in Bacteriophage Therapeutics
Introduction
Waleria Hryniewicz is a prominent inventor based in Warsaw, Poland. She has made significant contributions to the field of bacteriophage therapy, particularly in evaluating the therapeutic efficacy of these agents against pathogenic bacteria. Her innovative approach has the potential to enhance treatment options for infections in both humans and animals.
Latest Patents
Waleria Hryniewicz holds a patent for a method of evaluating the therapeutic efficacy of bacteriophages. This patent introduces a novel use of a nematode in assessing the effectiveness of bacteriophage preparations. The invention aims to improve treatment strategies for infections caused by harmful bacteria.
Career Highlights
Throughout her career, Waleria has worked with esteemed institutions such as the Institute of Biochemistry and Biophysics of the Polish Academy of Sciences and the Institute of Immunology and Experimental Therapy of the Polish Academy of Sciences. Her work in these organizations has allowed her to advance her research and contribute to the scientific community.
Collaborations
Waleria has collaborated with notable colleagues, including Malgorzata Lobocka and Aleksandra Glowacka. These partnerships have fostered a collaborative environment that enhances research and innovation in bacteriophage therapy.
Conclusion
Waleria Hryniewicz is a trailblazer in the field of bacteriophage therapeutics, with a focus on innovative methods for evaluating treatment efficacy. Her contributions are paving the way for new approaches to combat bacterial infections.